ELI LILLY & COMPANY LIMITED

About ELI LILLY & COMPANY LIMITED

ELI LILLY & COMPANY LIMITED is a global pharmaceutical company dedicated to creating innovative medicines that help improve the lives of patients around the world. Founded in 1876, the company has a rich history of scientific discovery and a commitment to advancing healthcare through research and development.

The company focuses on several therapeutic areas, including diabetes, oncology, immunology, and neurodegenerative diseases. With a strong emphasis on patient-centric solutions, ELI LILLY strives to address unmet medical needs and enhance treatment outcomes.

ELI LILLY operates in over 120 countries, employing thousands of professionals who are passionate about making a difference in the field of medicine. The company invests heavily in research and development, with a significant portion of its revenue allocated to discovering new therapies and improving existing ones.

In addition to its commitment to innovation, ELI LILLY is dedicated to corporate social responsibility. The company actively engages in initiatives aimed at increasing access to healthcare, supporting communities, and promoting sustainability.

• Core Values: Integrity, excellence, and respect for people.
• Vision: To make life better for people around the world through innovative medicines.
• Mission: To discover and develop medicines that help patients live longer, healthier lives.

With a robust pipeline of new products and a focus on collaboration with healthcare professionals, ELI LILLY & COMPANY LIMITED continues to lead the way in pharmaceutical advancements. The company’s dedication to science and patient care positions it as a trusted partner in the healthcare community.